References
- Brock, D. W. (2003). Separate spheres and indirect benefits. Cost Effectiveness and Resource Allocation, 1(1), 4. https://doi.org/https://doi.org/10.1186/1478-7547-1-4
- Carbone, M. (2007). Supporting or resisting global public goods? The policy dimension of a contested concept. Global Governance: A Review of Multilateralism and International Organizations, 13(2), 179–198. https://doi.org/https://doi.org/10.1163/19426720-01302004
- Chen, L. C., Evans, T. G., & Cash, R. A. (1999). Health as a global public good. In I. Kaul, I. Grunberg, & M. A. Stern (Eds.), Global public goods: International cooperation in the 21st century (pp. 284–304). Oxford University Press.
- Cornes, R., & Sandler, T. (1996). Public goods in general. In The theory of externalities, public goods, and club goods (2nd ed., pp. 240–299). Cambridge University Press.
- Coussy, J. (2005). The adventures of a concept: Is neo-classical theory suitable for defining global public goods? Review of International Political Economy, 12(1), 177–194. https://doi.org/https://doi.org/10.1080/09692290500049755
- Daniels, N. (2000). Accountability for reasonableness. BMJ, 321(7272), 1300–1301. https://doi.org/https://doi.org/10.1136/bmj.321.7272.1300
- Daniels, N. (2007). Just health: Meeting health needs fairly. Cambridge University Press.
- Duffy, K. (2020). We won't have enough COVID-19 vaccine for everybody until 2024, warns world's largest vaccine producer. Business Insider. https://www.businessinsider.com/covid-vaccine-wont-reach-everyone-for-four-years-serum-institute-2020-9
- Faunce, T. A. (2006). Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: Enhancing an endangered global public good. Globalization and Health, 2(1), 5. https://doi.org/https://doi.org/10.1186/1744-8603-2-5
- Fernholz, T. (2020, April 21). Why the US government isn’t making health a priority in its coronavirus response. Quartz, https://qz.com/1841531/why-us-isnt-making-health-a-priority-in-its-response-to-covid-19/
- Fidler, D. P. (2010). Negotiating equitable access to influenza vaccines: Global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. PLoS Medicine, 7(5), e1000247. https://doi.org/https://doi.org/10.1371/journal.pmed.1000247
- Gartner, D. (2012). Global public goods and global health. Duke Journal of Comparative & International Law 22(3), 303–318.
- GAVI. (2020). About our alliance. https://www.gavi.org/our-alliance/about
- IHME. (2020). Financing global health 2019: Tracking health spending in a time of crisis.
- Kaul, I. (2006). Public goods: A positive analysis. In J.-P. Touffut (Ed.), Advancing public goods (pp. 13–67). Edward Elgar Publishing.
- Kaul, I., Conceicao, P., Le Goulven, K., & Mendoza, R. U. (2003). How to improve the provision of global public goods. In Providing global public goods: Managing globalization (pp. 21–58). United Nations Development Program.
- Kaul, I., Grunberg, I., & Stern, M. A. (1999). Defining global public goods. In I. Kaul, I. Grunberg, & M. A. Stern (Eds.), Global public goods: International cooperation in the 21st century (pp. 2–19). Oxford University Press.
- Kaul, I., & Mendoza, R. U. (2003). Advancing the concept of public goods. In Providing global public goods: Managing globalization (pp. 78–111. United Nations Development Program.
- Love, J. (2020). The use and abuse of the phrase “global public good”. https://www.indiachinainstitute.org/2020/07/09/the-use-and-abuse-of-global-public-good/
- Lynch, C. (2020, January 21). Document of the week: Global plan for sharing vaccines. Foreign Policy, https://foreignpolicy.com/2020/07/31/document-of-the-week-global-plan-for-sharing-vaccines/
- Martinussen, J. (1997). Society, state and market: A guide to competing theories of development. Bloomsbury Academic.
- McNeil Jr., D. (2020, December 24). How much herd immunity is enough? The New York Times. https://www.nytimes.com/2020/12/24/health/herd-immunity-covid-coronavirus.html
- Moon, S., Røttingen, J.-A., & Frenk, J. (2017). Global public goods for health: Weaknesses and opportunities in the global health system. Health Economics, Policy and Law, 12(2), 195–205. https://doi.org/https://doi.org/10.1017/S1744133116000451
- Moore, D. (2004). The second age of the third world: From primitive accumulation to global public goods? Third World Quarterly, 25(1), 87–109. https://doi.org/https://doi.org/10.1080/0143659042000185354
- Müller, J.-W. (2011). Contesting democracy: Political thought in twentieth-century Europe. Yale University Press.
- Nordhaus, W. D. (2010). Some foundational and transformative grand challenges for the social and behavioral sciences: The problem of global public goods. American Economic Association, Ten Years and Beyond: Economists Answer NSF's Call for Long-Term Research Agendas.
- Norheim, O. F., Emanuel, E. J., & Millum, J. (2019). Global health priority-setting: Beyond cost-effectiveness. Oxford University Press.
- OECD. (2005). Paris declaration on aid effectiveness. https://www.oecd-ilibrary.org/content/publication/9789264098084-en
- Ottersen, T., & Norheim, O. F. (2014). Making fair choices on the path to universal health coverage. Bulletin of the World Health Organization, 92(6), 389. https://doi.org/https://doi.org/10.2471/BLT.14.139139
- Oxfam. (2020, September 17). Small group of rich nations have bought up more than half the future supply of leading COVID-19 vaccine contenders. https://www.oxfam.org/en/press-releases/small-group-rich-nations-have-bought-more-half-future-supply-leading-covid-19
- Ravelo, J. L. (2020). The ACT-accelerator needs $35B more funding. Here's what's at stake if it fails. Devex. https://www.devex.com/news/sponsored/the-act-accelerator-needs-35b-more-funding-here-s-what-s-at-stake-if-it-fails-98189
- Roberts, M. J., & Reich, M. R. (2002). Ethical analysis in public health. The Lancet, 359(9311), 1055–1059. https://doi.org/https://doi.org/10.1016/S0140-6736(02)08097-2
- Samuelson, P. A. (1954). The pure theory of public expenditure. The Review of Economics and Statistics, 36(4), 387–389. https://doi.org/https://doi.org/10.2307/1925895
- Schmidt, H., Gostin, L. O., & Williams, M. A. (2020). Is it lawful and ethical to prioritize racial minorities for COVID-19 vaccines? JAMA, 324(20), 2023–2024. https://doi.org/https://doi.org/10.1001/jama.2020.20571
- Sen, A. (1999). Global justice: Beyond international equity. In I. Kaul, I. Grunberg, & M. A. Stern (Eds.), Global public goods: International cooperation in the 21st century (pp. 121). Oxford University Press.
- Slobodian, Q. (2018). Globalists: The end of empire and the birth of neoliberalism. Harvard University Press.
- Sridhar, D. (2012). Who sets the global health research agenda? The challenge of multi-bi financing. PLoS Medicine, 9(9), e1001312. https://doi.org/https://doi.org/10.1371/journal.pmed.1001312
- Srinivasan, A. (2016). The equitable access initiative. https://www.theglobalfund.org/media/1322/eai_equitableaccessinitiative_report_en.pdf
- Stein, F., & Sridhar, D. (2017). Health as a “global public good”: Creating a market for pandemic risk. BMJ, 358, j3397. https://doi.org/https://doi.org/10.1136/bmj.j3397
- Stiglitz, J. E., & Rosengard, J. K. (2015). Economics of the public sector. W. W. Norton, Incorporated.
- t’Hoen, E., Berger, J., Calmy, A., & Moon, S. (2011). Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Journal of the International AIDS Society, 14(1), 15. https://doi.org/https://doi.org/10.1186/1758-2652-14-15
- Touffut, J. P. (2006). Advancing public goods. Edward Elgar.
- Usher, A. D. (2020). South Africa and India push for COVID-19 patents ban. The Lancet, 396(10265), 1790–1791. https://doi.org/https://doi.org/10.1016/S0140-6736(20)32581-2
- Wood, G., & Spiegel, D. (2020, March 21). COVID-19 vaccines are coming, but they’re not what you think. The Atlantic. https://www.theatlantic.com/ideas/archive/2020/03/two-extreme-long-shots-could-save-us-coronavirus/608539/
- World Health Assembly. (2020). COVID-19 response (A73/VR/2).
- World Health Organization. (2020a). COVAX announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021. https://www.who.int/news/item/18-12-2020-covax-announces-additional-deals-to-access-promising-covid-19-vaccine-candidates-plans-global-rollout-starting-q1-2021
- World Health Organization. (2020b). Fair allocation mechanism for COVID-19 vaccines through the COVAX facility. (https://www.who.int/publications/m/item/fair-allocation-mechanism-for-covid-19-vaccines-through-the-covax-facility
- World Health Organization. (2020c). International community rallies to support open research and science to fight COVID-19. https://www.who.int/news/item/29-05-2020-international-community-rallies-to-support-open-research-and-science-to-fight-covid-19
- World Health Organization. (2021). COVAX announces new agreement, plans for first deliveries. https://www.who.int/news/item/22-01-2021-covax-announces-new-agreement-plans-for-first-deliveries
- Zacher, M. W. (1999). Global epidemiological surveillance: International cooperation to monitor infectious diseases. In I. Kaul, I. Grunberg, & M. A. Stern (Eds.), Global public goods: International cooperation in the 21st century (pp. 266–84). Oxford University Press.